RT Journal Article
SR Electronic
T1 Transmission of SARS-CoV-2 in Norwegian schools: A population-wide register-based cohort study on characteristics of the index case and secondary attack rates
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.04.21264496
DO 10.1101/2021.10.04.21264496
A1 Torill Alise Rotevatn
A1 Vilde Bergstad Larsen
A1 Tone Kristin Bjordal Johansen
A1 Elisabeth Astrup
A1 Pål Surén
A1 Margrethe Greve-Isdahl
A1 Kjetil Telle
YR 2021
UL http://medrxiv.org/content/early/2021/10/07/2021.10.04.21264496.abstract
AB Objectives To assess transmission of SARS-CoV-2 in schools mainly kept open during the COVID-19 pandemic.Design Population-wide register-based cohort study.Setting Primary and lower secondary schools in Norway have been open during the academic year 2020/2021 with strict infection prevention and control (IPC) measures in place. All identified contacts including student and staff members were urged to get tested following a positive SARS-CoV-2 case in a school.Participants All students and educational staff in Norwegian primary and lower secondary schools from August 2020 to June 2021.Main outcome measures Overall secondary attack rate (SAR14) was operationalized as the number of secondary cases (among students and/or staff) in the school by 14 days after the index case, divided by the number of students and staff members in the school. Moreover, we calculated SAR14-to-students, denoting transmission from all index cases to students only, SAR14-to-school staff, denoting transmission from all index cases to staff members only. We also calculated these measures in stratified samples consisting of student index cases or school staff index cases.Results From August 2020 to June 2021 there were 4,078 index cases, 79% were students and 21% were school staff. In the majority (55%) of schools with an index case, no secondary cases were observed by 14 days, and in 16% of the schools there were only one secondary case within 14 days. Overall SAR14 was found to be 0.33% (95%CI 0.32-0.33). Staff-to-staff transmission (SAR14 0.45%, 95%CI 0.40-0.52) was found to be slightly more common than student-to-student (SAR14 0.33%, 95%CI 0.32-0.34) and student-to-staff (SAR14 0.28%, 95%CI 0.25-0.30) transmission.Conclusions Our results confirm that schools have not been an important arena of transmission of SARS-CoV-2 in Norway and therefore support that schools can be kept open with IPC measures in place.Competing Interest StatementAll authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work. PS have received a grant from the OAK Fellowships Programme in Molecular and Environmental Epidemiology (Grant number OCAY-12-356) and have acted as an expert witness in court cases for the National Office for Health Service Appeals. Other than this, no author had financial relationships with any organisations that might have an interest in the submitted work in the previous three years or report other relationships or activities that could appear to have influenced the submitted work.Funding StatementThe study was funded by the Norwegian Institute of Public Health, which was where the study was conducted. The institute had no direct role in the design and conduct of the study; compilation, analysis, and interpretation of data, writing of the manuscript, and decision to submit the manuscript for publication. No external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The emergency preparedness register, BEREDT C19, was established according to the Health Preparedness Act 2-4 and the project was approved by the Ethics Committee of South-East Norway (9th March 2021, #198964).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo additional data available. The datasets that support the findings of this study contain sensitive information and cannot be shared by the authors due to privacy laws. Individual-level data for research are generally available within Norway upon application conforming with strict regulations and procedures.